Regulus Therapeutics Adds Biogen Idec to its List of Partners with miRNA Biomarker Deal
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 31 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1795 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Regulus Therapeutics has signed its second deal in the space of a few days by partnering with Biogen Idec to identify microRNAs as biomarkers for multiple sclerosis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS